TriSalus Life Sciences, Inc. (TLSI) Earnings History
Net Loss6 years of earnings data (2020–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
TriSalus Life Sciences, Inc. (TLSI) Earnings Overview
As of June 28, 2026, TriSalus Life Sciences, Inc. (TLSI) reported trailing twelve-month net income of -$27M, reflecting -47.2% year-over-year growth. The company earned $-0.52 per diluted share over the past four quarters, with a net profit margin of -86.9%.
Looking at the long-term picture, TLSI's historical earnings data spans multiple years. The company achieved its highest annual net income of -$29M in fiscal 2021.
TriSalus Life Sciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NVCR (-$173M net income, -20.8% margin), ANGO (-$31M net income, -11.6% margin), IRTC (-$28M net income, -6.0% margin), TLSI has room to improve margins relative to the peer group. Compare TLSI vs NVCR →
TLSI Earnings vs Peers
Earnings metrics vs comparable public companies
TLSI Historical Earnings Data (2020–2025)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$39M | -18.0% | -$27M | $-1.84 | -86.9% | -59.7% |
| 2024 | -$33M | +44.0% | -$36M | $-1.25 | -112.9% | -122.9% |
| 2023 | -$59M | -25.8% | -$54M | $-2.23 | -320.7% | -294.3% |
| 2022 | -$47M | -63.6% | -$36M | $-1.59 | -380.6% | -293.9% |
| 2021 | -$29M | +9.4% | -$24M | $-0.92 | -343.4% | -286.1% |
| 2020 | -$32M | - | $-108,493 | $-0.02 | - | - |
Download Data
Export TLSI earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TLSI — Frequently Asked Questions
Quick answers to the most common questions about buying TLSI stock.
What is TLSI earnings per share (EPS)?
TLSI trailing twelve-month (TTM) diluted EPS is $-0.52, reflecting -47.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2020 to 2025 is available in the table on this page.
What is TriSalus Life Sciences, Inc.'s net income?
TriSalus Life Sciences, Inc. (TLSI) trailing twelve-month net income is $-27M as of 2025. Earnings declined -47.2% year-over-year.
Is TLSI profitable?
TLSI is not currently profitable on a TTM basis, reporting a net loss of $-27M. Net margin is -86.9%. Investors should monitor for a return to profitability.
What is TLSI's earnings growth rate?
TLSI compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2020 to 2025.
What are TLSI's profit margins?
TriSalus Life Sciences, Inc. net profit margin is -86.9%, operating margin is -59.7%, and gross margin is +84.6%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.
Is TLSI growing earnings?
TLSI earnings are declining — EPS fell -47.2% year-over-year. TTM net income dropped to $-27M. This contrasts with the 5-year CAGR of N/A.
What was TLSI's best earnings year?
TriSalus Life Sciences, Inc.'s highest annual net income on record is $-29M, achieved in fiscal year 2021. Earnings history on this page spans 2020 to 2025 and includes all annual and quarterly figures.
What were TLSI's earnings last quarter?
TLSI's most recent reported quarter was Q1 2026. Net income was $2M with diluted EPS of $0.03. For a full breakdown of all quarters, see the quarterly earnings table on this page.